Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer

Zuanel Diaz; Adriana Aguilar-Mahecha; Mark Basik; Dimcho Bachvarov; Luc Bélanger; Naciba Benlimame; Marguerite Buchanan; Errol Camlioglu; Benoit Chabot; André Constantin; Chantal Courtemanche; Thérèse Gagnon-Kugler; Lise Gosselin; Suzan McNamara; Michèle Orain; Eric Paquet; Ewa Przybytkowski; Samia Qureshi; Denis Rodrigue; Caroline Rousseau; Martin Simard; Alan Spatz; Bernard Têtu; Gerald Batist

doi:10.1158/1538-7445.AM2012-3389

Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer

Zuanel Diaz
, Adriana Aguilar-Mahecha
, Mark Basik
, Dimcho Bachvarov
, Luc Bélanger
, Naciba Benlimame
, Marguerite Buchanan
, Errol Camlioglu
, Benoit Chabot
, André Constantin
, Chantal Courtemanche
, Thérèse Gagnon-Kugler
, Lise Gosselin
, Suzan McNamara
, Michèle Orain
, Eric Paquet
, Ewa Przybytkowski
, Samia Qureshi
, Denis Rodrigue
, Caroline Rousseau

Martin Simard, Alan Spatz, Bernard Têtu, Gerald Batist

Herbert Wertheim Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer research
Volume	72
DOIs	https://doi.org/10.1158/1538-7445.AM2012-3389
State	Published - Apr 15 2012

Disciplines

Medicine and Health Sciences
Pathology

Access to Document

10.1158/1538-7445.AM2012-3389License: Unspecified

Cite this

Diaz, Z., Aguilar-Mahecha, A., Basik, M., Bachvarov, D., Bélanger, L., Benlimame, N., Buchanan, M., Camlioglu, E., Chabot, B., Constantin, A., Courtemanche, C., Gagnon-Kugler, T., Gosselin, L., McNamara, S., Orain, M., Paquet, E., Przybytkowski, E., Qureshi, S., Rodrigue, D., ... Batist, G. (2012). Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer. Cancer research, 72. https://doi.org/10.1158/1538-7445.AM2012-3389

Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer. / Diaz, Zuanel; Aguilar-Mahecha, Adriana; Basik, Mark et al.
In: Cancer research, Vol. 72, 15.04.2012.

Research output: Contribution to journal › Article › peer-review

Diaz, Z, Aguilar-Mahecha, A, Basik, M, Bachvarov, D, Bélanger, L, Benlimame, N, Buchanan, M, Camlioglu, E, Chabot, B, Constantin, A, Courtemanche, C, Gagnon-Kugler, T, Gosselin, L, McNamara, S, Orain, M, Paquet, E, Przybytkowski, E, Qureshi, S, Rodrigue, D, Rousseau, C, Simard, M, Spatz, A, Têtu, B & Batist, G 2012, 'Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer', Cancer research, vol. 72. https://doi.org/10.1158/1538-7445.AM2012-3389

Diaz Z, Aguilar-Mahecha A, Basik M, Bachvarov D, Bélanger L, Benlimame N et al. Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer. Cancer research. 2012 Apr 15;72. doi: 10.1158/1538-7445.AM2012-3389

@article{9a6501652602446e98e9a6d65a66e7de,

title = "Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer",

author = "Zuanel Diaz and Adriana Aguilar-Mahecha and Mark Basik and Dimcho Bachvarov and Luc B{\'e}langer and Naciba Benlimame and Marguerite Buchanan and Errol Camlioglu and Benoit Chabot and Andr{\'e} Constantin and Chantal Courtemanche and Th{\'e}r{\`e}se Gagnon-Kugler and Lise Gosselin and Suzan McNamara and Mich{\`e}le Orain and Eric Paquet and Ewa Przybytkowski and Samia Qureshi and Denis Rodrigue and Caroline Rousseau and Martin Simard and Alan Spatz and Bernard T{\^e}tu and Gerald Batist",

note = "Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Introduction: The biomarker discovery process requires patient tissue samples from which histology is verified and high-quality genomic material is isolated. Several methods have been developed to either preserve tissue morphology or extract sufficient quality and quantity of RNA and DNA for downstream discovery efforts.",

year = "2012",

month = apr,

day = "15",

doi = "10.1158/1538-7445.AM2012-3389",

language = "American English",

volume = "72",

journal = "Cancer research",

}

TY - JOUR

T1 - Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer

AU - Diaz, Zuanel

AU - Aguilar-Mahecha, Adriana

AU - Basik, Mark

AU - Bachvarov, Dimcho

AU - Bélanger, Luc

AU - Benlimame, Naciba

AU - Buchanan, Marguerite

AU - Camlioglu, Errol

AU - Chabot, Benoit

AU - Constantin, André

AU - Courtemanche, Chantal

AU - Gagnon-Kugler, Thérèse

AU - Gosselin, Lise

AU - McNamara, Suzan

AU - Orain, Michèle

AU - Paquet, Eric

AU - Przybytkowski, Ewa

AU - Qureshi, Samia

AU - Rodrigue, Denis

AU - Rousseau, Caroline

AU - Simard, Martin

AU - Spatz, Alan

AU - Têtu, Bernard

AU - Batist, Gerald

N1 - Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Introduction: The biomarker discovery process requires patient tissue samples from which histology is verified and high-quality genomic material is isolated. Several methods have been developed to either preserve tissue morphology or extract sufficient quality and quantity of RNA and DNA for downstream discovery efforts.

PY - 2012/4/15

Y1 - 2012/4/15

UR - http://cancerres.aacrjournals.org/content/72/8_Supplement/3389

U2 - 10.1158/1538-7445.AM2012-3389

DO - 10.1158/1538-7445.AM2012-3389

M3 - Article

VL - 72

JO - Cancer research

JF - Cancer research

ER -

Abstract 3389: Determining optimal conditions for collection and processing of metastatic liver biopsies collected for a multicenter, prospective study to identify biomarkers of clinical resistance to first-line therapy in metastatic colorectal cancer

Disciplines

Access to Document

Other files and links

Cite this